Wellell マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Daniel Lee

最高経営責任者

n/a

報酬総額

CEO給与比率	n/a
CEO在任期間	no data
CEOの所有権	0.8%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	5.4yrs

経営陣の近況

Recent updates

Should You Or Shouldn't You: A Dividend Analysis on Apex Medical Corp. (TPE:4106)

Mar 29

Reflecting on Apex Medical's (TPE:4106) Share Price Returns Over The Last Five Years

Mar 01

Returns On Capital At Apex Medical (TPE:4106) Paint An Interesting Picture

Feb 11

Weak Financial Prospects Seem To Be Dragging Down Apex Medical Corp. (TPE:4106) Stock

Jan 27

Is Apex Medical (TPE:4106) Using Too Much Debt?

Jan 12

Is Apex Medical Corp. (TPE:4106) A Good Fit For Your Dividend Portfolio?

Dec 28

Does Apex Medical's (TPE:4106) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 13

Apex Medical (TPE:4106) Share Prices Have Dropped 28% In The Last Five Years

Nov 27

CEO（最高経営責任者

Daniel Lee

no data

在職期間

Mr. Daniel Lee is Founder and CEO of Wellell Inc. He was President, GM & Chairman of Wellell Inc. from August 01, 2021. He was President & Chairman of Wellell Inc. until August 01, 2021. Mr. Lee was Sales...

取締役

名称	ポジション	在職期間	報酬	所有権
Yong-Chuan Li	Chairman of the Board & GM	no data	データなし	1.4% NT$ 34.8m
James Wang	Independent Director	5.4yrs	データなし	データなし
Wan Lin	Independent Director	11.4yrs	データなし	データなし
Yan Zhou	Supervisors	no data	データなし	データなし
Jin Li	Supervisor	no data	データなし	データなし
Der-Zen Liu	Representative Director	no data	データなし	データなし
Hsiung-Ching Lee	Independent Director	5.4yrs	データなし	データなし
Charles Liu	Director	no data	データなし	データなし
William Wang	Independent Director	no data	データなし	データなし
Peter Lin	Independent Director	no data	データなし	データなし

5.4yrs

平均在職期間

経験豊富なボード: 4106の取締役会は経験豊富であると考えられます ( 5.4年の平均在任期間)。

Wellell マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

Wellell Inc. Appoints Su Ya-Ling as Chief Operating Officer

Wellell Inc., Annual General Meeting, Jun 24, 2024

Wellell Inc. Appoints Lee Pi Kai as Chief Strategy Officer

Wellell Inc. Announces Resignation of Tan, Jian-Qiang as Chief Operating Officer

Wellell Inc. Appoints Shin-Ho,Chen as Corporate Governance Officer

Insufficient new directors

Recent updates

Some May Be Optimistic About Wellell's (TWSE:4106) Earnings

Third quarter 2024 earnings released: EPS: NT$0.08 (vs NT$0.24 in 3Q 2023)

Wellell Inc. to Report Q3, 2024 Results on Nov 11, 2024

New minor risk - Profit margin trend

Second quarter 2024 earnings released: EPS: NT$0.21 (vs NT$0.50 in 2Q 2023)

Wellell Inc. to Report Q2, 2024 Results on Aug 13, 2024

Upcoming dividend of NT$0.80 per share

Wellell's (TWSE:4106) Dividend Is Being Reduced To NT$0.80

Wellell (TWSE:4106) Has Announced That Its Dividend Will Be Reduced To NT$0.80

Dividend reduced to NT$0.80

Wellell Inc. Approves Common Stock Cash Dividend, Payable on August 26, 2024

First quarter 2024 earnings released: EPS: NT$0.40 (vs NT$0.50 in 1Q 2023)

Wellell Inc. to Report Q1, 2024 Results on May 08, 2024

Wellell Inc. to Report Q1, 2024 Results on May 08, 2024

Some May Be Optimistic About Wellell's (TWSE:4106) Earnings

Wellell Inc. Appoints Su Ya-Ling as Chief Operating Officer

Full year 2023 earnings released: EPS: NT$1.51 (vs NT$1.60 in FY 2022)

Wellell Inc., Annual General Meeting, Jun 24, 2024

Wellell Inc. Appoints Lee Pi Kai as Chief Strategy Officer

Wellell Inc. Announces Resignation of Tan, Jian-Qiang as Chief Operating Officer

Second quarter 2023 earnings released: EPS: NT$0.50 (vs NT$0.51 in 2Q 2022)

Upcoming dividend of NT$0.85 per share at 2.7% yield

New minor risk - Dividend sustainability

Investor sentiment improves as stock rises 16%

Wellell Inc. Appoints Shin-Ho,Chen as Corporate Governance Officer

Full year 2022 earnings released: EPS: NT$1.60 (vs NT$1.01 in FY 2021)

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: NT$0.59 (vs NT$0.31 in 3Q 2021)

Insufficient new directors

Wellell Inc. Announces Change Member of Remuneration Committee

Second quarter 2022 earnings released: EPS: NT$0.51 (vs NT$0.34 in 2Q 2021)

Insufficient new directors

Apex Medical Corp. Approves Cash Dividend for the Year 2021

Apex Medical Corp. Announces Change of Alan Chang as Research and Development Officer, Effective May 31, 2022

Apex (Kunshan)Medical Corp. to Announce Production Can Be Resume Gradually

Apex Medical Corp. Announces On Behalf of the Subsidiaries Apex (Kunshan) Medical Corp. and Wellell (Kunshan) Co., Ltd. Extend Temporary Suspension of Production

Wellell (Kunshan) Co., Ltd. Announces the Temporary Suspension of Production

Full year 2021 earnings released: EPS: NT$1.01 (vs NT$1.04 in FY 2020)

Wellell Inc., Annual General Meeting, Jun 20, 2022

Third quarter 2021 earnings released: EPS NT$0.31 (vs NT$0.28 in 3Q 2020)

High number of new directors

High number of new directors

High number of new directors

Upcoming dividend of NT$0.55 per share

Second quarter 2021 earnings released: EPS NT$0.34 (vs NT$0.55 in 2Q 2020)

High number of new directors

High number of new directors

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS NT$0.29 (vs NT$0.074 in 1Q 2020)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS NT$1.04 (vs NT$0.87 in FY 2019)

Should You Or Shouldn't You: A Dividend Analysis on Apex Medical Corp. (TPE:4106)

Reflecting on Apex Medical's (TPE:4106) Share Price Returns Over The Last Five Years

Apex Medical Corp. Announces Executive Changes, Effective March 01, 2021

Returns On Capital At Apex Medical (TPE:4106) Paint An Interesting Picture

Apex Medical Corp. Appoints Alan Chang as Director of R&D

New 90-day low: NT$25.65

Weak Financial Prospects Seem To Be Dragging Down Apex Medical Corp. (TPE:4106) Stock

Is Apex Medical (TPE:4106) Using Too Much Debt?

New 90-day low: NT$28.00

Is Apex Medical Corp. (TPE:4106) A Good Fit For Your Dividend Portfolio?

Does Apex Medical's (TPE:4106) Statutory Profit Adequately Reflect Its Underlying Profit?

New 90-day low: NT$28.90

Apex Medical (TPE:4106) Share Prices Have Dropped 28% In The Last Five Years

Third quarter 2020 earnings released: EPS NT$0.28

New 90-day low: NT$31.05

First half earnings released

CEO（最高経営責任者

マネジメント基準チェック /14